Trial Profile
A retrospective study investigating the effect of imatinib in patients with chronic myeloid leukemia from Georgia Cancer Specialists electronic medical record (EMR) system
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 28 Nov 2015 New trial record